BioCentury
ARTICLE | Financial News

Pfizer Ventures leads Strata's $26M series B

May 23, 2018 7:55 PM UTC

Strata Oncology Inc. (Ann Arbor, Mich.) raised $26 million in a series B round led by Pfizer Ventures. Fellow new investors Merck Global Health Innovation Fund, Deerfield Management and Renaissance Venture Capital Fund participated, as did existing investors Arboretum Ventures and Baird Capital.

Strata is developing platforms to expand patient access to precision medicine clinical trials. The company plans to sequence tumors from 100,000 patients for free as part of its Strata Trial observational study, which seeks to match patients to clinical studies of targeted therapies based on their tumors' genetic profiles using the StrataNGS test. The next-generation sequencing molecular profiling assay sequences DNA and RNA...